Subcutaneous engineered factor VIIa marzeptacog alfaactivated n hemophilia with inhibitorsPhase 2 trial of pharmacokinetics pharmacodynamics efficacy and safety

Simple item page
dc.citation.doi10.1002/RTH.12576
dc.citation.epage12
dc.citation.spage1
dc.contributor.authorJohnny Mahlangu
dc.contributor.authorHoward Levy
dc.contributor.authorMarina Kosinova
dc.contributor.authorHeghine Khachatryan
dc.contributor.authorBartosz Korczowski
dc.date.accessioned2023-04-13T10:22:05Z
dc.date.available2023-04-13T10:22:05Z
dc.identifier.citationDOAJ
dc.identifier.issn2475-0379
dc.identifier.urihttps://hdl.handle.net/10539/35000
dc.journal.titleRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS
dc.journal.volume5
dc.titleSubcutaneous engineered factor VIIa marzeptacog alfaactivated n hemophilia with inhibitorsPhase 2 trial of pharmacokinetics pharmacodynamics efficacy and safety

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal.pdf
Size:
1.28 MB
Format:
Adobe Portable Document Format
Description:
Journal
Download

Collections

Academic Wits Research Outputs (All submissions)